Groupe la Francaise’s COSCIENS Biopharma Inc. Common Stock CSCI Stock Holding History

Groupe la Francaise’s Portfolio CSCI Stock Details CSCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-1	Closed	-$3	–	829
2025 Q2	$3	Hold	1	–	–	﹤0.01%	441
2025 Q1	$3	Hold	1	–	–	﹤0.01%	440
2024 Q4	$8	Buy	+1	New	+$3	﹤0.01%	331

Other funds holding CSCI

TWC

TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Groupe la Francaise's CSCI Position: Q3 2025 in Review

Groupe la Francaise sold out of COSCIENS Biopharma Inc. Common Stock (CSCI) in Q3 2025, closing a stake of 1 share — an estimated $3 sold.

Groupe la Francaise first reported a position in CSCI in Q4 2024 and held it in 3 quarters. The position peaked at $8 in Q4 2024. 2 funds tracked by Wall St. Rank hold CSCI as of Q3 2025.

Groupe la Francaise reported no remaining COSCIENS Biopharma Inc. Common Stock position as of Q3 2025 after selling out during the quarter.
Groupe la Francaise sold 1 COSCIENS Biopharma Inc. Common Stock share in Q3 2025, an estimated $3.
Groupe la Francaise first reported a position in COSCIENS Biopharma Inc. Common Stock in Q4 2024 and held it in 3 quarters.
Groupe la Francaise's COSCIENS Biopharma Inc. Common Stock position peaked at $8 in Q4 2024.
2 funds tracked by Wall St. Rank held COSCIENS Biopharma Inc. Common Stock as of Q3 2025.

Based on Groupe la Francaise's 13F filing for Q3 2025, filed 13 Nov 2025.